Show simple item record

dc.contributor.authorPegg, Neil
dc.contributor.authorWorthington, Jenny
dc.contributor.authorYoung, Barbara
dc.contributor.authorProsser, Amy
dc.contributor.authorGaughan, Luke
dc.contributor.authorSpencer, Gary J
dc.contributor.authorSomervaille, Tim CP
dc.contributor.authorBurns, Julie
dc.contributor.authorKnowles, Margaret
dc.contributor.authorBrooks, Nigel
dc.date.accessioned2019-09-11T09:09:11Z
dc.date.available2019-09-11T09:09:11Z
dc.date.issued2018en
dc.identifier.citationPegg N, Worthington J, Young B, Prosser A, Gaughan L, Spencer G, et al. Abstract 3991: Novel small molecule inhibitors of p300/CBP down-regulate androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond. Cancer Res. 2018;78(13):3991.en
dc.identifier.doi10.1158/1538-7445.AM2018-3991en
dc.identifier.urihttp://hdl.handle.net/10541/621978
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1158/1538-7445.AM2018-3991en
dc.titleNovel small molecule inhibitors of p300/CBP down-regulate androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyonden
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCellCentric Ltd., Cambridge, UKen
dc.identifier.journalCancer Researchen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record